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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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MONDAY, FEBRUARY 11, 2013

‘No Marine deserted on the battlefield’: two surviving
spouses join forces to speed the defeat of
Huntington’s disease
After the deadly, untreatable Huntington’s disease claimed their spouses,
Jonathan Monkemeyer and Jane Mervar – once strangers, now close –
decided to devote their lives to finding ways to speed the search for
effective remedies and making the case for the importance of juvenile HD
(JHD) in the process.
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Without at first knowing the cause of his wife Sheryl’s strange illness,
Jonathan quit his job in the early 2000s to become her full-time caregiver
until she died from HD in 2009 at 46.
“It’s the thing you have to do,” Jonathan, an accomplished electrical
engineer, said in a recent phone interview from his home in suburban
Philadelphia. “You really don’t have a choice in our country. We did a lot of
nice things, which was good. We did peaceful things like traveling to local
gardens. She spent a lot of time with our son.”
Sheryl died at home. “I didn’t expect her to die,” Jonathan said. “I thought
we would get the cure in time. The doctor said she had five years. But she
fell and got hurt. She couldn’t sit. I had to hold her. Her weight went from
109 pounds to 89 pounds within four weeks. She died of a heart attack,
which is like starving to death.”
Caring for Sheryl depleted the family’s life savings, Jonathan added. “I’m
heating with wood right now,” he said. “I’m not using heating oil.”
The couple’s son Jonathan, now 14, has a 50-50 chance of having inherited
the HD gene from his mother. (Usually only adults can decide whether to
be tested for the gene, and most choose not to do so. Children can be tested
if they already show symptoms.)
A parallel story
Halfway across the country in the village of L’Anse in the Upper Peninsula
of Michigan, Jane faced her own difficult odyssey to decipher the disease
afflicting her family. She lost not only her 49-year-old husband Karl, but
also her 13-year-old daughter Karli Mukka to HD, both in early 2010.
(Jane gave her daughters her maiden name.)
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“Karl was a wonderful, ambitious, intelligent man,” Jane said at the start of
an exhausting and emotional four-hour interview. “He had very strong
family values. He could always make me laugh.”
However, she recounted, gradually “he started to change. Nobody could
explain to me what was going on.”
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Karl Mervar and daughter Karli Mukka, both victims of HD (family
photo)
Like many HD patients, Karl became angry and aggressive, threatening his
family with violence.
“Karl held us hostage with his guns,” Jane said, recalling the dangers she,
Karli, and her three other daughters faced as Karl’s behavior became
increasingly irrational. “There were a lot of scary, scary times. We had a
safe room in the house. We’d go in the room and push the bed up against
the door. The girls knew this routine. Then I would try to play with him or
try to distract him.
“The darn thing is, I knew we were everything left in the world that meant
anything to him.”
JHD ravaged Karli’s body, displacing the organs in her chest cavity and
forcing her spine to the far side. Because of the disease’s uncontrollable
movements, Karli had chewed off half of her tongue by the time she died,
Jane said.
A nurse suggested that Jane give Karli morphine and “let her go.” She
declined the advice.
“It was a hard spot to be in,” Jane said. “I talked to Karli and asked her if
she was ready to go on baby Jesus’s lap. She said no. She died of natural
causes.”
Today Jane just gets by financially, thanks to Social Security benefits, as
she cares full-time for her two other daughters with Karl, 22-year-old Erica
Mukka and 20-year-old Jacey Mukka. Like Karli, both have JHD. Karisa
Mukka, a 26-year-old daughter from a previous relationship, lives nearby.
Partners in love and advocacy
In June 2010, still in mourning for their lost loved ones, Facebook friends
Jonathan and Jane struck up a lively conversation while sitting next to
each other at the 25th convention of the Huntington’s Disease Society of
America (HDSA) in Raleigh, NC. After the convention, they spoke daily for
at least a couple of hours. Jonathan visited L’Anse, and shortly thereafter
Jane and Jacey stayed nine days with the Monkemeyers.
Their friendship led Jonathan and Jane into a romantic, long-distance
relationship.
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“They’re an incredible family,” Jonathan said of Jane and her daughters.
“Their value system is not about themselves.”
“I was in a pretty low place,” Jane recalled. “I had lots of grief after Karli
and Karl died. I wanted a reprieve from caregiving – just wanted to be
dead. I’d be laughing after I finished talking to Jonathan. I think he saved
me.”
Their relationship and support for each other’s families also became a
partnership in advocacy for HD patients.
Bridging the gaps
To achieve their goals, Jonathan and Jane are politely but firmly
challenging bureaucratic inertia.
Supporting himself and his son with his son’s Social Security survivor
benefits, Jonathan dedicates himself full-time to HD advocacy. He has
developed a deep understanding of HD science. By his account, he has so
far skimmed through more than 10,000 scientific articles related to the
disease.
Applying an engineering approach to the problem of developing
treatments, Jonathan developed a website, HDCircle.org, currently offline,
on which he has posted information about HD researchers from around
the world, links to HD organizations, and reviews of potential HD
treatments. He plans to reactivate the site soon.
He also created a Facebook discussion page, Hereditary Disease Circle,
with the goal of finding connections between HD and other neurological
conditions such as Parkinson’s disease, multiple sclerosis, posttraumatic
stress disorder, and amyotrophic lateral sclerosis, also known as Lou
Gehrig’s disease.
In addition, he attends relevant meetings and conferences in order to
network with people from other disease communities. He seeks to bring
their best results and ideas to bear on HD research.
As Jonathan explained, he aims to create “synergies” and “bridge the gaps”
among HD researchers and the various key organizations such as HDSA,
the Hereditary Disease Foundation (HDF), the CHDI FoundationInc., the
multi-million-dollar, non-profit virtual biotech formed solely to seek HD
treatments, and the National Institutes of Health (NIH).
As one example, Jonathan said he has spoken personally with NIH
Director Dr. Francis Collins, one of the pioneers in the search for the HD
gene in the 1980s and 1990s, more than a dozen times, including last week
in Washington, D.C.
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NIH Director Francis Collins (left) and Jonathan Monkemeyer (personal
photo)
“Essentially, engineers design things hierarchically,” Jonathan explained.
“I created a website, which is a blueprint for how the system works.
“We’re the only disease without a gene therapy. There have been 1,000
gene therapy clinical trials. But we as a community don’t seem to be
organized enough. There’s something in our organizational structure. By
their very nature of having a job description, when you’re within an
organization, your function is to be in the organization. Everybody gets
stuck in a silo of what they’re doing. With so many scientists and
stakeholders in the field of HD research, moving forward gets stymied by
committee and the sense of urgency gets tuned out.”
If he held a position within one of the organizations, “I’d have a boss to
report to,” Jonathan continued. “As an outsider, without a job, and asking
questions as an advocate, it gives you the position to help steer people in
the right direction towards what needs to be done. I have the greatest
freedom, not being employed in an organization. I can talk to anybody I
want to.”
Sometimes Jonathan feels as if he’s “walking on egg shells, because I’m not
a researcher,” he said. “You tell people very nicely and very artfully. We
don’t tear down institutions. We build them up.”
He summed up his approach as “doing what needs to be done to drive
innovation that will bring a therapeutic to our community.”
What might work
Significantly, Jonathan’s efforts include canvassing the research
community for the latest discoveries and techniques that could translate
into therapies for HD. He seeks to brainstorm about new developments, as
well as previous ones, in his conversations with scientists.
Rather than simply await for the multi-million-dollar pharmaceutical
efforts to bring results, advocates must actively participate in the search
for treatments, perhaps even trying drugs and substances approved for
other purposes in their own off-label studies, seeking advice from
researchers on dosing, and having people reporting their observations via
a website, Jonathan suggested.
He cited the example of Hannah’s Hope Fund (HHF), whose advocates
teamed with researchers in a low-cost effort to develop gene therapy for a
rare genetic condition known as giant axonal neuropathy. HHF has met
curehd.blogspot.com/2013/02/no-marine-deserted-on-battlefield-two.html
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with the federal Food and Drug Administration (FDA) and, if a safety
study goes as planned, could start a clinical trial this year.
In the drug-discovery system in America, the profit motive “stymies
innovation and responsibility” towards the patients, Jonathan observed.
Rather than producing strong leaders like a Jonas Salk, who developed the
vaccine for polio, the system today fosters a climate of “let’s make
everybody happy.”
Jonathan also pointed to the new partnership between the NIH and the
Milken Institute/Faster Cures, which seeks to increase collaboration
among the government, foundations, universities, and the pharmaceutical
industry in order to cure more diseases and do it faster. This initiative
includes the creation of a new NIH program, the National Center for
AdvancingTranslational Sciences.
Advocates for rare diseases like HD need “to get involved in every single
aspect” of the search for treatments.
“AIDS advocates made the FDA bend,” he noted. “We the patients have a
moral incentive. Our voice counts and makes the difference.”
An epiphany about JHD
Like other JHD advocates, Jane and Jonathan have strived to increase the
attention to JHD by researchers, HD organizations, and the government.
In September 2010, Jonathan and Jane met with Dr. Steve Groft, the
director of the Office of Rare Diseases Research at the NIH, to press the
case for greater support for HD research.
For Jonathan and Jane, the meeting was a kind of epiphany. Pointing to
the different emphases and the existence of different organizations in the
field of diabetes and juvenile diabetes, Groft helped them see the key role
that JHD research could play in the overall HD effort.

Dr. Steve Groft and Jane Mervar. In the middle is Max the Turtle, Karli’s
stuffed animal companion that is now a mascot of the JHDKids initiative
(family photo).
“The meeting was phenomenal,” Jane said. Jonathan said she came away
with a greater sense of “we need to do something.”
“Everybody was so resistant to acknowledge the juvenile population,” Jane
said. “It’s just like some big political game. Nobody was playing that game
for our children, so we were screaming: we need a cure, we need a cure,
we need a cure!”
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“You need a piece of legislation to get JHD funded, and then the NIH
would fund it,” Jonathan explained, pointing to one of the roadblocks
facing the efforts to understand and treat JHD.
Both Jonathan and Jane observed that JHD research lags far behind other
HD research, and, because of ethical concerns and the need to avoid
mixing juvenile and adult research data, children aren’t included in clinical
trials.
Jane tried but failed to sign up Karli for a trial for ACR-16, seen as a
potentially promising HD remedy. Jane described the formal response she
received as “too bad for you, you have Juvenile HD.” “I was devastated,”
she said.
Karli also took the supplement creatine, currently under study for HD and
taken by many in the community. “It took us almost a year to get two
doctors to follow Karli when she was on creatine and to get a guideline on
dosage,” Jane recalled. “There are a lot of families that are just slipping
through the cracks.”
Researchers have also lacked a so-called “natural history study” of JHD – a
study to follow a group of patients over an extended period to better
understand the condition and support the development of treatments.
Jane and Jonathan’s advocacy has included pressing the HD organizations
to pay greater attention to JHD, they said. Thanks to pressure from JHD
families, last year HDSA agreed to the creation of a new fundraising effort
specifically for JHD, Jane explained.
“Great things can be created from hard situations,” Jane observed.

Jonathan and Jane at the White House after their meeting at the NIH
Office of Rare Diseases and Research (family photo)
Raising the profile of JHD
Jane, her daughters, and other JHD families swung into action, joining
other grassroots JHD initiatives in the effort to raise awareness and funds
for research.
curehd.blogspot.com/2013/02/no-marine-deserted-on-battlefield-two.html
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Jacey and Erica started JHDKids.com. With a computer and video
equipment provided by the Make-a-Wish Foundation, Jacey has made a
series of short films, including one about Karl and Karli titled The Real
Huntington’s Disease, which has had more than 220,000 views on
YouTube. (Watch the video below.)

The Real Huntington's Disease

The JHDKids initiative is seeking funds specifically to support the JHD
research of Dr. Jane Paulsen, the co-director of the HDSA Center of
Excellence at the University of Iowa, and project partner Dr. Martha
Nance, the director of the HDSA Center of Excellence in Minneapolis.
Both researchers work on a volunteer basis, with all funds raised going
solely to research.
In the words of the JHDKids site, JHD differs significantly from adult
onset HD in several ways. “The most significant difference is that in JHD
the disease occurs before the brain is fully developed,” says a statement on
the site from the researchers. “This accounts for the wide variation at one
age from JHD to another age. Maturation and neurodegeneration occur at
the same time in JHD.”
Drs. Paulsen and Nance began following JHD patients at the annual HDSA
conventions in order to carry out the natural history study.
“Now, with the awareness and fundraising getting more widespread,
they’re able to bring our families into Iowa,” Jane explained. “We’re
planning on going this spring. That will be the first time we’re going to
Iowa.”
One big family
Jonathan and Jane have talked of bringing their families together in one
place.
For now, however, they will continue their hours-long daily conversations
from their respective abodes. Jonathan’s location on the East Coast
facilitates his access to the corridors of scientific and medical power, while
Jane wants to respect Jacey’s wish to die in the same place as her sister
and father.
The distance does not diminish their commitment to each other’s families,
nor to the larger cause.
curehd.blogspot.com/2013/02/no-marine-deserted-on-battlefield-two.html
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Jonathan helps Jane manage her caregiving crises. “He’s always learning
something new,” she said. “He’s a very faithful, spiritual person. He’s just a
very good man.”
Erica and Jacey’s doctors wouldn’t predict how long they might live,
although JHD patients typically die in their 20s or 30s, if not sooner, like
Karli.
Jane knows that an effective, life-saving treatment might not come in time
to save them. She concentrates on providing them with the healthiest,
happiest life possible. Having worked as a nurse’s aide in a nursing home
and seen Karl go through his final decline in such a home, she hopes to
keep her girls at home as long as possible.
“Jacey has a big phobia that if she can’t see me, she’ll die,” Jane said. “We
can’t calm that down. She likes to watch movies. She likes to work on the
website. She likes to see all the kids with JHD. She likes to come up with
new ideas for designing the website.”
At 19, Erica had married her high school sweetheart, but the marriage
lasted only 11 months. She is currently dating another man. “She wants
him to learn how to do her makeup and coordinate her clothing,” said
Jane, who has legal guardianship over both daughters.
She obtained a court order to obtain permission for a tubal ligation for
Erica.
“I cried with her,” Jane said. “It was just a real painful process to go
through. She said, ‘If I had a baby and got sicker, and what if my baby’s
like Karli?’”
“Fear for my son is certainly a reason,” said Jonathan of his commitment
to the HD cause, noting that, so far, his son has showed no HD symptoms.
“That’s a personal, selfish motivation. Why is my son’s life more important
than someone else’s life? I know Jacey and Erica and everybody else that’s
dying from this.”
He added, “I’m doing this full time, and as far as I’m concerned, there’s
nothing more important I can do with my life. It’s knowing everybody in
the community and knowing the suffering and the damage it causes to
families. You don’t leave a marine in the battlefield. It’s just wrong to walk
away. I can’t stop doing it. This is my life experience.”
His experiences as Sheryl’s caregiver have deepened his feelings about
others facing the same plight.
“When I see HD in somebody else, the empathy is much more intense and
overwhelming,” he confided. “To me, we’re all a big family. That’s why I
can’t walk away.”
Posted by Gene Veritas at 4:10 PM
Labels: advocacy , CHDI , clinical trial , cure , gene therapy , HDF , HDSA ,
hereditary , Huntington's disease , juvenile Huntington's , NIH , nursing home ,
pharmaceutical , research , science , symptoms , treatments
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This comment has been removed by the author.
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Gene, are you now advising your readers to take off label drugs
and seek advice from researchers for dosing? As you wrote
from your interview with Mr. Monkeymeyer...
"Rather than simply await for the multi-million-dollar
pharmaceutical efforts to bring results, advocates must actively
participate in the search for treatments, perhaps even trying
drugs and substances approved for other purposes in their own
off-label studies, seeking advice from researchers on dosing,
and having people reporting their observations via a website,
Jonathan suggested."
**Not only is this illegal for a researcher to advise on dosing
[this should only be done by a licensed physician], but no
researcher will jeopardize a human being or their license and
livelihood. This could potentially harm or even kill someone.
Gene Veritas I'm really surprised that you would write this illadvised content in your blog.
12:29 PM, February 12, 2013

Anonymous said...
Just a sign of the helplessness and desperation a person with
HD or a family member feels watching their loved ones suffer
with no treatment or cure in sight.
5:45 PM, February 12, 2013

Anonymous said...
I get it what melisa said and I feel the same way. I am a
christian woman and watch every day how this hd is but we
have to be safe and see our doctor!! I had left a group on
facebook because of to much going on and to much nonsence
Blessed all who are sufferring AMEN!
8:11 AM, February 13, 2013

Anonymous said...
Gene, your articles are always so beautifully written. This one
hits home even more as I know the people involved. Jonathon
and Jane serve selflessly to move the therapy and cure forward.
Jonathon's opportunity and ability to brainstorm with
scientists is so good for the cause. This allows him to take a step
back and look outside the box. The research community is
usually driven by profit. These two are working for real people
and living on a shoe string to propel their ideas forward. I
appreciate Jane and Jonathon's efforts from the bottom of my
heart. Thank you again Gene for you way with words.
10:19 AM, February 13, 2013

Anonymous said...
I am afraid that I am worried about the advice about the other
drugs and substances for our people. I think it is unsafe and it
is giving people bad advice without a doctor involved.
curehd.blogspot.com/2013/02/no-marine-deserted-on-battlefield-two.html
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I also removed myself from their group and their drama like
the other person it is just so sad but we cant be around it
anymore.
Irene
2:28 PM, February 15, 2013

Anonymous said...
Thanks Gene, for highlighting Jane's story. I've heard it befoe
and it has brought tears to my eyes several times. She is strong
and brave, and I'm pleased to hear that she has found someone
to share her journey with. May their work to bring light to this
disease go well.
3:53 PM, February 17, 2013

Anonymous said...
It was a wonderful blog.. and Melissa.. your comment is really
dissapointing. You would think you would want to help expose
morw research.. i couldnt find where anyone was saying to take
a suplemnet.
Pretty sad when one advcote attacks another.. you may not
agree with john or Gene but to attack dose nothig to help.
Tara Hansen
6:38 PM, February 12, 2014

Anonymous said...
Huntingdont's disease can't get a cure until there is either a
discovery that would come from another field that works out
how to switch off, or greatly slow down the impact of the cag
repeats.
Too few persons from afflicted families are prepared to actively
do their part in getting tested early in life to provide sufficient
data re numbers carrying the gene, potential for researchers to
be able to analyse the varying courses if the disease, be in a
position to almost eliminate any JHD cases and a majority of
future adult onset cases of HD.There will be always a small
number of HD gene positive persons while unsymptomatic who
had utterly no notion of the possibility of their status. and
hence passing it on through no information of a parent carrier.
The cases of obscured extra late familial onset could be a
source, though if HD was actually made truly widely
recognisable as a condition, it's symptoms etc.,it would
increase their younger generations members to check out for
the condition.Too much familial underplaying or even partial
efforts of concealment of HD, shame, fear of others more
widely knowing of the condition impacts on elimination.
Secondly the fear of supposed insurance, employment,plus
justifying remaining ignorant as it's too upsetting to know if
positive need to be countered. Few end up collecting great
insurance plus employment ends not by gene positive status
curehd.blogspot.com/2013/02/no-marine-deserted-on-battlefield-two.html
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but by diease onset. Finally the understandable but selfish
desire to have a spouse and kids so push it into the denial
optimism basket where due to low public knowledge spouses
ignore the hints of the familial disease they heard hit some
relatives.The rule ought to be if an at risk person thinks the
prospect of finding out is unbearablely awful, it's obviously too
awful a disease to transmit by having children aside by now
pre-implantation selectiveness with no info to diulge gene
status or earlier to have used donor gametes or adoption or no
kids.Too many think I'd rather I was born while
unsymptomatic but at risk, ought to be good enough for next
generation, then devestated and guilt ridden once symptomatic
or have a child with JHD.
More if the money raised by HD organisations needs to go into
altering widespread awareness, bringing the disease out of the
closet, prevention of it's transmission, working on highly
effective treatments for symptoms after onset, securing quality
services to care for persons comfortably, prompt income
assistance when low incomes need benefits. It's inexcusable
that a large proportion of JHD cases who need need have
occured with identifying testing having been available from the
early 90's.Or young persons being at risk.
I did a contract for a HD organisation 16 years ago, the same
mantra of they'll find a cure, we need one with heads in the
sand, few testing their status, yet not much has changed at all,
especially in effective symptom managed treatments which is
where for the ones to become symptomatic the best hopes
could lie to reduce the horror and terror of the ineitable
progression. Until then all efforts ought to be in preventing
anyone you can be born at risk. If they do however find a cure
or close enough to by effective slowing, then those at risk can
tumble their dice of hopeful chances.
What's interesting is that in all that fund raising no HD
organisation does divulge the actual money and man power of
research efforts that can be evaluated in numerous directly
likely to be effective results or if they are ever shared with other
researchers in parrallel genetic fields. I've the greatest
sympathy for those dealing with the disease, admiration for so
many dealing corageously and tirelessly with the impact of this
condition. Our engineers concerns were great to be raised. The
HD organisations though wonderful in much of the work and
support they deliver have gotten too entrenched, dogmatic,
dominant in forcing unquestioning compliance by other
professional bodies working alongside of them causing a
stagnation impeding progress that's possible.
6:36 PM, October 13, 2014
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